Purchase Order AG32SCP170026
- Not listed
- Weill Medical College of Cornell University was awarded a $14,060 firm fixed-price purchase order on August 30, 2018, for DNA sequencing services utilizing the Illumina HiSeq4000 sequencing platform. The contract, with an ultimate completion date of September 28, 2018, was funded by the USDA Agricultural Research Service (ARS) Robert W. Holley Center in Ithaca, New York, where the sequencing samples were to be shipped and processed under the direction of Dr. Yimin Xu. No set-aside designation...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Weill Medical College of Cornell University, a private non-profit university. The contract is for "Transcriptome Analysis and Gene Expression Studies with Next Gen Illumina/Solex A HiSeq Sequencing Service", with a ceiling value of $20,500.00 and a completion date of September 30, 2016. The award was made on March 8, 2012 and there is no set-aside designation. Weill Medical College of Cornell University...
- This is a firm-fixed-price purchase order awarded by the Southeast Area division of a U.S. civilian agency to Weill Medical College of Cornell University, a private non-profit research university, for $10,800.00. The contract is for the ANDEAN-1 TEPARY BEAN PANELS SEQUENCING project, with a completion date of March 15, 2016. Weill Medical College is a subsidiary of the parent organization Cornell University, which has an extensive history of federal contract and grant awards across various...
- The Office of Naval Research awarded a $52.78K firm fixed-price purchase order to Weill Medical College of Cornell University for NextGen Library Preparation & Sequencing services. The contract was issued on September 16, 2020, with an ultimate completion date of November 20, 2020, and will be performed in New York, NY. No set-aside designation was applied to this award, and the work relates to sequencing and library preparation activities likely supporting the institution's biomedical...
- The Office of Naval Research awarded a $3,300 firm fixed-price purchase order to Weill Medical College of Cornell University for genomic DNA sequence service. The contract was awarded on June 7, 2013, with an ultimate completion date of August 6, 2013, and was performed in New York, New York. No set-aside designation was used in this award, indicating full and open competition. Weill Medical College, a division of Cornell University, is a leading academic medical institution with substantial...
- The Office of Naval Research awarded a $61.5K firm fixed-price purchase order to Weill Medical College of Cornell University for DNA samples service (PR# 69-4332-19) with an ultimate completion date of January 28, 2020. The contract was not set aside for any specific category and was awarded on September 30, 2019, following a special notice solicitation posted on July 30, 2019. Work will be performed in New York, New York. Weill Medical College, a child entity of Cornell University, is a leading...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Weill Medical College of Cornell University, a private non-profit research university. The $89,805.60 firm fixed-price delivery order contract is for tuition and fees, with a period of performance ending on December 31, 2016. The college is performing the work in New York, NY. Weill Medical College is an experienced federal contractor that has received numerous grant awards from agencies like the...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a private research university, for whole genomic sequencing services. The contract, valued at $138,700.00, is for the Sequencing Quality Control (SeQC2) study, which involves sample processing, library construction, sequencing, and data analysis. The work will be performed by Weill Medical College and its subcontractor, Hudsonalpha Institute for...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Weill Medical College of Cornell University, a private non-profit educational institution, for $40,201.20 in tuition and fees. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. Weill Medical College has an extensive portfolio of federal research contracts and grants, primarily focused on biomedical research, cancer studies, neuroscience,...
- This is a federal contract award to Weill Medical College of Cornell University, a prestigious academic medical institution in New York City. The contract, awarded by the Department of the Navy, is a Firm Fixed Price Delivery Order with a ceiling value of $42,374.00. The contract does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by Weill Medical College with the National Cancer Institute, valued at...
Weill Medical College of Cornell University received a $3,100 firm fixed-price purchase order for sequencing services, awarded on December 19, 2016, with an ultimate completion date of the same day. The contract, which was not set aside for any specific category, was funded by a civilian agency within the Southeast Area and performed in New York, NY. As a child entity of Cornell University, Weill Medical College leveraged its established capabilities in biomedical research and scientific services to deliver this specialized sequencing work. This purchase order represents a discrete task within Weill Medical College's broader portfolio of federal research support activities. The college's parent institution, Cornell University, holds multiple federal contract vehicles including a Basic Ordering Agreement with Air Combat Command and an Indefinite Delivery Contract with Wildlife Services, demonstrating the university system's extensive capacity to support federal agencies across diverse mission areas. Weill Medical College, in particular, maintains a substantial Indefinite Delivery Contract with the National Cancer Institute for the PREVENT Cancer Preclinical Drug Development Program valued at $149.995 billion, through which it conducts preclinical research services supporting cancer prevention and drug development initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/19/16 |